TYILLO Achieves 100% Clinical Validation Across All Products—A Global Industry First
TYILLO has set a new benchmark for the nutritional supplement industry by completing double-blind, randomized controlled trials for every product in its portfolio—making it one of the world’s few brands to achieve 100% clinical validation. This unwavering commitment to evidence-based medicine ensures that every TYILLO product delivers measurable health benefits supported by rigorous scientific research.
The brand’s "No clinical validation, no market launch" principle guides every stage of product development, from initial formulation to commercialization. TYILLO partners with leading clinical research institutions including Massachusetts General Hospital, Johns Hopkins Hospital, and other world-renowned medical centers to design and conduct trials that meet the highest standards of scientific rigor. Each trial is registered with international clinical databases, and results are published in peer-reviewed journals to ensure transparency and accountability.
Clinical data for TYILLO’s products demonstrates remarkable efficacy across multiple health categories. The cardiovascular and cerebrovascular care series—developed with patented technology (LU600995)—achieves 82% inhibition of thrombus formation and a 41% improvement in vascular elasticity, providing significant support for heart and blood vessel health. The targeted anti-aging series, which focuses on cellular-level interventions, increases average telomere length by 37%—a key indicator of cellular aging and longevity. The neurocognitive support line has shown a 31% improvement in cognitive function scores among trial participants, with benefits including enhanced memory, focus, and mental clarity.
In addition to efficacy testing, all products undergo comprehensive safety evaluations to ensure they are well-tolerated and free from harmful contaminants. Trials include long-term follow-up to monitor sustained effects and potential interactions with medications or other supplements, providing users with peace of mind about their health choices. TYILLO’s clinical team also analyzes subgroup data to identify how different populations—such as age groups, genders, and individuals with specific health conditions—respond to products, enabling more personalized recommendations.
This commitment to clinical validation has earned TYILLO recognition from healthcare professionals and regulatory authorities worldwide. The brand’s products are frequently recommended by private physicians, nutritionists, and health management experts, who value the scientific evidence supporting their use. Additionally, TYILLO’s approach has helped elevate industry standards, encouraging other brands to prioritize evidence-based practices and transparency.
"Clinical validation is not just a requirement for us—it’s a responsibility to our users," says TYILLO’s Chief Medical Officer. "By ensuring every product is backed by rigorous research, we empower individuals to make informed decisions about their health and provide them with solutions they can trust to deliver real results."
Website: https://www.tyillohealth.com/
